Jia Wei

21PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityRespiratory diseasesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 27, 2026
Hypoxia-inducible CEA-targeted CAR T-cell therapy for relapsed stage IV non-small cell lung cancer.

|Aug 05, 2026
Novel highly selective ROCK2 inhibitor (TDI01) for the treatment of chronic graft-versus-host disease: a multicenter, open-label phase Ib/II study.

|Aug 04, 2026
Endoplasmic reticulum stress promotes leukemic plasmacytoid dendritic cell differentiation skewing and immune suppression in acute myeloid leukemia.

|Jun 30, 2026
Advances and prospects in cell therapy for cancer: explorations from T cells to stem cells.

|Jun 24, 2026
Febrile neutropenia adversely affects chemomobilization outcomes in patients with multiple myeloma and increases risk for post-transplant infection in those with lymphoma: real-world multicenter data.

|Feb 12, 2026
Long-term follow-up demonstrates the curative potential of dual CD19/CD22 CAR-T-cell therapy alone or combined with autologous stem cell transplantation in TP53-altered relapsed/refractory B-cell non-Hodgkin lymphoma.

Zekai Mao, Juan Peng, Yang Cao

Pageof 4

Frequent Collaborators

5 joint publications

Yicheng Zhang

3 joint publications

Xingcheng Yang

3 joint publications

Lifang Huang

2 joint publications

Chunrui Li